90.

Leaguetable with network estimates of all pairwise comparisons for efficacy (total number of skeletal‐related events) and acceptability (grade 3 to 4 adverse events). Treatments are presented in alphabetical order. Data are risk ratios (RRs) with corresponding 95% confidence intervals. For both efficacy and acceptability, RRs lower than 1 favor the first treatment in alphabetical order. To obtain RRs for comparisons in the opposite direction, reciprocals should be taken. Results not including the line of no effect in their confidence intervals and therefore suggesting evidence for a difference, are marked bold.